Alteration in phase I and II enzyme activities and polycyclic aromatic hydrocarbons-DNA adduct formation by plant phenolics in mouse epidermis

Nutrition and Cancer

Volumn 48, Issue 1, 2004, Pages 70-77

  Szaefer, Hanna ^a   Cichocki, Michał ^a   Brauze, Damian ^b   Baer Dubowska, Wanda ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF HUMAN GENETICS   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; BENZO[A]PYRENE; DIHYDROXYBENZO[A]PYRENE OXIDE; DNA; FERREDOXIN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE REDUCTASE; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; PHENOL DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON; PROTOCATECHUIC ACID; RESVERATROL; TRIHYDROXYSTILBENE; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; COVALENT BOND; DNA ADDUCT; DRUG ACTIVITY; ENZYME ACTIVITY; EPIDERMIS; FEMALE; MOUSE; MUTAGENICITY; NONHUMAN; PROTEIN DNA BINDING;

ANIMALIA;

EID: 3042641988     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc4801_10     Document Type: Article

References (63)

1. Stoner GD and Mukhtar H: Polyphenols as cancer chemopreventive agents. J Cell Biochem 22(Suppl), 169-180, 1995.
2. Spanos GA and Wrolstad RE: Phenolics of apple, pear and white grape juices and their changes with processing and storage: a review. J Agric Food Chem 40, 1478-1487, 1992.
3. Newmark H: Plant phenolics as inhibitors of mutational and pre-carcinogenic events. Can J Physiol Pharmacol 65, 461-466, 1987.
4. Yang CS, Lee MJ, Chen L, and Yang G: Polyphenols as inhibitors of carcinogenesis. Environ Health Perspect 105, 971-976, 1997.
5. De Flora S: Mechanisms of inhibitors of mutagenesis and carcinogenesis. Mutat Res 402, 151-158, 1998.
6. Ueno A: The studies on the constituents and the utilization in Citrus species. Foods Food Ingredients J 157, 46-53, 1993.
7. Tanaka T, Kojima T, Kawamori T, Yoshimi N, and Mori H: Chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis by a simple phenolic acid, protocatechuic acid in rats. Cancer Res 53, 2775-2779, 1993.
8. Tanaka T, Kawamori T, Ohnishi M, Okamoto K, Mori H, and Hara A: Chemoprevention of 4-nitroquinoline-1-oxide-induced oral carcinogenesis by dietary protocatechuic acid during initiation and post-initiation phase. Cancer Res 54, 2359-2365, 1994.
9. Kawamofi T, Tanaka T, Kojima T, Suzui M, Ohnishi M, and Mofi H: Suppression of azoxymethane-induced rat colon aberrant crypt foci by dietary protocatechuic acid. Jpn J Cancer Res 85, 686-691, 1994.
10. Tanaka T, Kojima T, Kawamofi T, and Mofi H: Chemoprevention of digestive organs carcinogenesis by natural product protocatechuic acid. Cancer 75(Suppl), 1433-1439, 1995.
11. Hirose Y, Tanaka T, Kawamofi T, Ohnishi M, Makita H, et al.: Chemoprevention of urinary bladder carcinogenesis by the natural phenolic compound protocatechuic acid in rats. Carcinogenesis 16, 2337-2342, 1995.
12. Ohnishi M, Yoshimi N, Kawamori T, Ino N, Hirose Y, et al.: Inhibitory effects of dietary protocatechuic acid and costunolide on 7,12-dimethylbenz[a] anthracene-induced hamster cheek pouch carcinogenesis. Jpn J Cancer Res 88, 111-119, 1997.
13. Tseng TH, Hsu JD, Lo MH, Chu CY, Chou FP, Huang CL, and Wang CJ: Inhibitory effect of Hibiscus protocatechuic acid on tumor promotion in mouse skin. Cancer Lett 126, 199-207, 1998.
14. Exon JH, Magnuson BA, South EH, and Hendrix K: Effect of dietary chlorogenic acid on multiple immune functions and formation of aberrant crypt foci in rats. J Toxicol Environ Health 53, 375-384, 1998.
15. Mori H, Tanaka T, Shima H, Kuniyasu T, and Takahashi M: Inhibitory effect of chlorogenic acid on methylazoxymethanol acetate-induced carcinogenesis in large intestine and liver of hamsters. Cancer Lett 30, 49-54, 1986.
16. Tanaka T, Kojima T, Kawamori T, Wang A, Suzui M, Okamoto K, and Mori H: Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids. Carcinogenesis 14, 1321-1325, 1993.
17. Mori H, Tanaka T, Sugie S, Yoshimi N, Kawamori T, Hirose Y, and Ohnishi M: Chemoprevention by naturally occurring and synthetic agents in oral, liver, and large bowel carcinogenesis. J Cell Biochem 27(Suppl), 35-41, 1997.
18. Kasai H: Formation of 8-hydroxyguanine in DNA by oxygen radicals (in Japanese). Environ Mut Res Commun 16, 264-274, 1995.
19. Kasai H, Fukada S, Yamaizumi Z, Sugie S, and Mori H: Action of chlorogenic acid in vegetables and fruits as an inhibitor of 8-hydroxydeoxyguanosine formation in vitro and in a rat carcinogenesis model. Food Chem Toxicol 38, 467-471, 2000.
20. Chung KT, Stevens SE Jr, Lin WF, and Wie CI: Growth inhibition of selected food-borne bacteria by tannic acid, propyl gallate and related compounds. Lett Appl Microbiol 17, 29-32, 1993.
21. Vance RE and Teel RW: Effect of tannic acid on rat liver S9 mediated mutagenesis, metabolism and DNA binding of benzo[a]pyrene. Cancer Lett 47, 37-44, 1989.
22. Mukhtar H, Das M, Khan WA, Wang ZY, Bik DP, and Bickers DR: Exceptional activity of tannic acid among naturally occurring plant phenols in protecting against 7,12-dimethylbenz[a]anthracene-, benzo[a]pyrene-, 3-methylcholantrene-, and N-methyl-N- nitrosourea-induced skin tumorigenesis in mice. Cancer Res 48, 2361-2365, 1988.
23. Khan WA, Wang ZY, Athar M, Bickers DR, and Mukhtar H: Inhibition of the skin tumorigenicity of (+/-)-7-beta,8-alpha-dihydroxy-3-alpha, 10-alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene by tannic acid, green tea polyphenols and quercetin in Sencar mice. Cancer Lett 42, 7-15, 1988.
24. Baer-Dubowska W, Gnojkowski J, and Fenrych W: Effect of tannic acid on benzo[a]pyrene-DNA adduct formation in mouse epidermis: comparison with synthetic gallic acid esters. Nutr Cancer 29, 42-47, 1997.
25. Krajka-Kuźniak V and Baer-Dubowska W: The effects of tannic acid on cytochrome P450 and phase II enzymes in mouse liver and kidney. Toxicol Lett 143, 209-216, 2003.
26. Ignatowicz E, Balana B, Vulimiri SV, Szaefer H, and Baer-Dubowska W: The effect of plant phenolics on the formation of 7,12-dimethylbenz[a]anthracene-DNA adducts and TPA. Stimulated polymorphonuclear neutrophils chemiluminescence in vitro. Toxicology 189, 199-209, 2003.
27. Lin J-K and Tsai S-H: Chemoprevention of cancer and cardiovascular disease by resveratrol. Proc Natl Sci Counc ROC (B) 23, 99-106, 1999.
28. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, et al.: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218-220, 1997.
29. Elmets CA: Cutaneous photocarcinogenesis. In Pharmacology of the Skin, Mukhtar H (ed). Boca Raton, FL: CRC Press, 1992, pp 389-401.
30. Henriksen T, Dahlback A, Larsen SH, and Moan J: Ultraviolet radiation and skin cancer. Effect of an ozone layer depletion. Photochem Photobiol 5, 579-582, 1990.
31. Mukhtar H, Mercurio MG, and Agarwal R: Murine skin carcinogenesis: relevance to humans. In Skin Cancer: Mechanisms and Human Relevance, Mukhtar H (ed). Boca Raton, FL: CRC Press, 1993, pp 3-8.
32. Nesnow S: Mouse skin tumors and human lung cancer: relationships with complex environmental emissions. IRAC Sci Publ 104, 44-54, 1990.
33. Nesnow S: Mouse skin tumors as predictors of human lung cancer for complex emissions: an overview. Prog Clin Biol Res 298, 347-361, 1989.
34. DiGiovanni J: Multistage carcinogenesis in mouse skin. Pharmacol Ther 54, 63-128, 1992.
35. Baer-Dubowska W: Mouse skin model as a reliable short-term carcinogenesis assay. Acta Pol Toxicol 5, 9-23, 1997.
36. Alexandrov K and Rojas-Moreno M: In vivo DNA adduct formation by benzo[a]pyrene in mouse and rat epidermal and dermal fibroblasts after topical application of an initiating dose of benzo[a]pyrene. Arch Geschwulstforsch 60, 329-340, 1990.
37. Rahn RO, Chung SS, Holland JM, and Shugart LR: A fluorometric-HPLC assay for quantitating the binding of benzo[a]pyrene metabolites to DNA. Biochem Biophys Res Commun 109, 262-268, 1982.
38. Lowry OH, Rosenbrough NJ, Farr AL, and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265-275, 1951.
39. Nebert DW and Gelboin HV: Substrate-inducible microsomal aryl hydrocarbon hydroxylase in mammalian cell culture. I. Assay and properties of induced enzyme. J Biol Chem 243, 6242-6249, 1968.
40. Jacoby WB: Detoxication and drug metabolism: conjugation and related systems. Methods Enzymol 77, 169-177, 1981.
41. Emster L: DT-diaphorase. Methods Enzymol 10, 309-317, 1967.
42. Benson AM, Barretto PB, and Stanley JS: Induction of DT-diaphorase by anticarcinogenic sulfur compounds in mice. JNCI 76, 467-473, 1986.
43. Habig WH, Pabs MJ, and Jakoby WB: Glutathione S-transferase. The first enzymatic steps in mercapturic acid formation. J Biol Chem 249, 7130-7139, 1974.
44. Baer-Dubowska W, Morris RJ, Gill RD, and DiGiovanni J: Distribution of covalent DNA adducts in mouse epidermal subpopulations after topical application of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene. Cancer Res 50, 3048-3054, 1990.
45. Ashurst SW, Cohen GM, Nesnow S, DiGiovanni J, and Slaga TJ: Formation of benzo[a]pyrene/DNA adducts and their relationship to tumor initiation in mouse epidermis. Cancer Res 43, 1024-1029, 1983.
46. Vahakangas K, Haugen A, and Harris CC: An applied synchronous fluorescence spectrophotometric assay to study benzo[a]pyrene-diolepoxide-DNA adducts. Carcinogenesis 6, 1109-1116, 1985.
47. Brauze D, Mikstacka R, and Baer-Dubowska W: Formation and persistence of benzo[a]pyrene DNA adducts in different tissues of C57BL/10 and DBA/2 mice. Carcinogenesis 12, 1607-1611, 1991.
48. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 7, 1543-1551, 1986.
49. Tang MS, Vulimiri SV, Viaje A, Chen JX, Biliokar DS, et al.: Both (±) anti-7,12-dmethylbenz[a]anthracene-3,4-diol-1,2-epoxides initiate tumors in mouse skin that possess -CAA- to -CTA-mutations at codon 61 ofc-Ha-ras. Cancer Res 60, 5688-5695, 2000.
50. Baer-Dubowska W, Szaefer H, and Krajka V: Inhibition of murine hepatic cytochrome P450 activities by natural and synthetic phenolic compounds. Xenobiotica 28, 735-743, 1998.
51. Kleiner HE, Vulimiri SV, Reed MJ, Uberecken A, and DiGiovanni J: Role of cytochrome P450 1a1 and 1b1 in the metabolic activation of 7,12-dimethylbenz[a] anthracene and the effects of naturally occurring furanocoumarins on skin tumor initiation. Chem Res Toxicol 15, 226-235, 2002.
52. Teel RW: Ellagic acid binding to DNA as a possible mechanism for its antimutagenic and anticarcinogenic action. Cancer Lett 30, 329-336, 1986.
53. Khan NS, Ahmad A, and Hadi SM: Anti-oxidant, pro-oxidant properties of tannic acid and its binding to DNA. Chem-Biol Interact 125, 177-189, 2000.
54. Casper RF, Quesne M, Rogers IM, Shirota T, Jolivet A, Milgrom E, and Savouret JF: Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol Pharmacol 56, 784-790, 1999.
55. Gonzalez FJ and Kimura S: Understanding the role of xenobiotic-metabolism in chemical carcinogenesis using gene knockout mice. Mut Res 477, 79-87, 2001.
56. Buters J, Quintanilla-Martinez L, Schober W, Soballa VJ, Hintermair J, et al.: CYP1B1 determines susceptibility to low doses of 7,12-dimethylbenz[a] anthracene-induced ovarian cancers in mice: correlation of CYP1B1-mediated DNA adducts with carcinogenicity. Carcinogenesis 24, 327-334, 2003.
57. Chun YJ, Kim S, Kim D, Lee SK, and Guengerich FP: A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis. Cancer Res 61, 8164-8170, 2001.
58. Yen GC, Duh PD, and Lin CW: Effects of resveratrol and 4-hexylresorcinol on hydrogen peroxide-induced oxidative DNA damage in human lymphocytes. Free Radic Res 37, 509-514, 2003.
59. Yu C, Shin YG, Chow A, Li Y, Kosmeder JW, et al.: Human, rat, and mouse metabolism of resveratrol. Pharm Res 19, 1907-1914, 2002.
60. Nebert DW, Puga A, and Vasiliou V: Role of the Ah receptor and dioxin-inducible [Ah] gene battery in toxicity, cancer and signal transduction. Ann NY Acad Sci 685, 624-640, 1993.
61. Talalay P, Prochaska HJ, and Spencer SR: Regulation of enzymes that detoxify the electrophilic forms of chemical carcinogenesis. In Xenobiotics and Cancer, Ernster L et al. (eds). Tokyo: Japan Scientific Societies Press, 1991, pp 177-187.
62. Merk HF and Jugert FK: Cutaneous NAD(P)H:quinone reductase: a xenobiotica-metabolizing enzyme with potential cancer and oxidation stress-protecting properties. Skin Pharmacol 4(Suppl 1), 95-100, 1991.
63. Baron JM, Holler D, Schiffer R, Frankenberg S, Neis M, Merk HF, and Jugert FK: Expression of multiple cytochrome p450 enzymes and multi resistance-associated transport proteins in human skin keratinocytes. J Invest Dermatol 116, 541-548, 2001.